Web Results

www.mayoclinic.org/diseases-conditions/idiopathic-thrombocytopenic-purpura/...

Treatment. People with mild immune thrombocytopenia may need nothing more than regular monitoring and platelet checks. Children usually improve without treatment. Most adults with ITP will eventually need treatment, as the condition often becomes severe or long term (chronic).

www.scripps.edu/mcmillan/experimental_therapy.html

Potentially useful new forms of treatment for chronic ITP will be briefly described in this section, explaining the reasons why these treatments may be helpful. In addition, there are preliminary results using some of these therapies and these are described and referenced.

emedicine.medscape.com/article/202158-treatment

Immune thrombocytopenic purpura (ITP)—also known as idiopathic thrombocytopenic purpura and, more recently, as immune thrombocytopenia—is a clinical syndrome in which a decreased number of circulating platelets (thrombocytopenia) manifests as a bleeding tendency, easy bruising (purpura), or extravasation of blood from capillaries into skin an...

www.webmd.com/a-to-z-guides/thrombocytopenia-symptoms-causes-treatments

WebMD explains the causes, symptoms, and treatment of thrombocytopenia and ITP, conditions that cause you to have an abnormally low number of platelets in your blood.

www.healthline.com/health/understanding-itp/itp-treatment-options

Learn more about ITP, the treatments available for managing it, how each works, and the possible side effects. Subscribe. Content created by Healthline and sponsored by our partners.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4948655

Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated clearance of platelets caused by antiplatelet autoantibodies. A platelet count in peripheral blood <100 × 10 9 /L is the most important criterion for the diagnosis of ITP. However, the platelet count is not the sole diagnostic criterion, and the ...

www.pharmacytimes.com/contributor/ayesha-khan-pharmd-bcps/2017/01/treatment...

The following article provides a brief overview of ITP and considerations for selected treatment options. ITP is characterized by low platelets due to immunologic destruction and decreased platelet production in the absence of an identifiable cause. 1 It is often times a diagnosis of exclusion as there are no reliable lab tests to confirm the ...

www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm604956.htm

On April 17, 2018, the Food and Drug Administration approved fostamatinib disodium hexahydrate tablets (TAVALISSE, Rigel Pharmaceuticals, Inc.) for the treatment of thrombocytopenia in adult ...

www.hematology.org/Thehematologist/Mini-Review/8728.aspx

Immune thrombocytopenia (ITP) is an acquired bleeding disorder with a heterogeneous and incompletely understood pathophysiology. The complex interplay of abnormalities, including immune dysregulation, antiplatelet autoantibodies, defects in cellular immunity, and altered platelet production, result in often profound thrombocytopenia and variable bleeding symptoms. 1 For decades, treatment ...

www.myitplife.com/en/living-with-itp

Treatments for ITP. The goals of ITP treatment are to prevent bleeding and maintain your platelet count at a safe level with minimal side effects. It’s not unusual for a doctor to try several different treatments for ITP to find what works best. Take a look below to see how different treatments work.